

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000011"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000011" />

    <meta name="citation_title" content="A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories"/>
    <meta itemprop="name" content="A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories"/>

      <meta name="citation_author" content="Matthew E. Falagas"/>
            <meta name="citation_author_institution" content="Alfa Institute of Biomedical Sciences, Athens, Greece"/>
            <meta name="citation_author_institution" content="Department of Medicine, “Henry Dunant” Hospital, Athens, Greece"/>
            <meta name="citation_author_institution" content="Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America"/>
      <meta name="citation_author" content="Konstantinos N. Fragoulis"/>
            <meta name="citation_author_institution" content="Alfa Institute of Biomedical Sciences, Athens, Greece"/>
            <meta name="citation_author_institution" content="Department of Medicine, “Henry Dunant” Hospital, Athens, Greece"/>
      <meta name="citation_author" content="Ioannis Karydis"/>
            <meta name="citation_author_institution" content="Alfa Institute of Biomedical Sciences, Athens, Greece"/>

    <meta name="citation_date" content="2006/12/20"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000011.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e11"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_volume" content="1"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Emerging role of pharmacoeconomics in the research and development decision-making process.; citation_author=JA DiMasi; citation_author=E Caglarcan; citation_author=M Wood-Armany; citation_journal_title=Pharmacoeconomics; citation_volume=19; citation_number=1; citation_pages=753-766; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.; citation_author=JA DiMasi; citation_author=RW Hansen; citation_author=HG Grabowski; citation_author=L Lasagna; citation_journal_title=Pharmacoeconomics; citation_volume=7; citation_number=2; citation_pages=152-169; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Projecting future drug expenditures.; citation_author=B Mehl; citation_author=J Santell; citation_journal_title=Am J Health Syst Pharm; citation_volume=58; citation_number=3; citation_pages=125-33; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Pharmacoeconomics: an emerging discipline.; citation_author=C Letizia; citation_journal_title=Qual Assur; citation_volume=4; citation_number=4; citation_pages=68-74; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=The price of innovation: new estimates of drug development costs.; citation_author=JA DiMasi; citation_author=RW Hansen; citation_author=HG Grabowski; citation_journal_title=J Health Econ; citation_volume=22; citation_number=5; citation_pages=151-85; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=The need for new therapeutic agents: what is the pipeline?; citation_author=PM Shah; citation_journal_title=Clin Microbiol Infect; citation_volume=11; citation_number=6; citation_pages=36-42; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital.; citation_author=ME Falagas; citation_author=SK Kasiakou; citation_author=D Nikita; citation_author=P Morfou; citation_author=G Georgoulias; citation_journal_title=BMC Infect Dis; citation_volume=6; citation_number=7; citation_pages=99; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Disease Society of America.; citation_author=GH Tablot; citation_author=J Bradley; citation_author=JE Edwards; citation_author=D Gilbert; citation_author=M Scheld; citation_journal_title=Clin Infect Dis; citation_volume=42; citation_number=8; citation_pages=657-68; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=World Wide Web resources on antimicrobial resistance.; citation_author=ME Falagas; citation_author=EA Karveli; citation_journal_title=Clin Infect Dis; citation_volume=43; citation_number=9; citation_pages=630-3; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Trends in antimicrobial drug development: implications for the future.; citation_author=B Spellberg; citation_author=JH Powers; citation_author=EP Brass; citation_author=LG Miller; citation_author=JE Edwards; citation_journal_title=Clin Infect Dis; citation_volume=38; citation_number=10; citation_pages=1279-86; citation_date=2004; " />
      <meta name="citation_reference" content="citation_number=11; " />
      <meta name="citation_reference" content="citation_number=12; citation_date=2004; citation_publisher=New Jersey; " />
      <meta name="citation_reference" content="citation_title=The costs of conducting clinical research.; citation_author=EJ Emanuel; citation_author=LE Scnipper; citation_author=DY Kamin; citation_author=J Levinson; citation_author=AS Lichter; citation_journal_title=J Clin Oncol; citation_volume=21; citation_number=13; citation_pages=4145-4150; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=New science-based endpoints to accelerate oncology drug development.; citation_author=GJ Kelloff; citation_author=CC Sigma; citation_journal_title=Eur J Cancer; citation_volume=41; citation_number=14; citation_pages=491-501; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=The cost of chemotherapy.; citation_author=C Levy; citation_author=J Bonastre; citation_journal_title=Bull Cancer; citation_volume=90; citation_number=15; citation_pages=976-982; citation_date=2003; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories"/>
    <meta name="twitter:description" content="BackgroundDrug treatment is becoming more expensive due to the increased cost for the introduction of new drugs, and there seems to be an uneven distribution of medication cost for different therapeutic categories. We hypothesized that the cost of new antimicrobial agents may differ from that of other therapeutic categories and this may play a role in the stagnation of development of new antibiotics.Methodology/Principal FindingsWe performed a pharmaco-economical comparative analysis of the drug cost of treatment for new agents introduced in the United States drug market in various therapeutic categories. We calculated the drug cost (in US dollars) of a ten-day treatment of all new drugs approved by the FDA during the period between January 1997 and July 2003, according to the 2004 Red Book Pharmacy's Fundamental Reference. New anti-neoplastic agents were found to be the most expensive drugs in comparison to all other therapeutic categories, with a median ten-day drug-treatment cost of US$848 compared to the median ten-day drug-treatment costs of all other categories ranging from US$29 to US$301. On the other hand, new antimicrobial drugs were found to be much less expensive, with a median ten-day drug-treatment cost of US$137 and $US85 for all anti-microbial agents and for anti-microbial agents excluding anti-HIV medications, respectively.Conclusions/SignificanceThe drug-treatment cost of new medications varies considerably by different therapeutic categories. This fact may influence industry decisions regarding the development of new drugs and may play a role in the shortage of new antimicrobial agents in the fight against the serious problem of antimicrobial resistance."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000011.t002"/>

  <meta property="og:title" content="A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=5658'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=8289'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=1588&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000011">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000011" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000011&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Matthew E. Falagas
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:matthew.falagas@tufts.edu">matthew.falagas@tufts.edu</a>
            </p>

                <p>Affiliations:
                  Alfa Institute of Biomedical Sciences, Athens, Greece, 
                  Department of Medicine, “Henry Dunant” Hospital, Athens, Greece, 
                  Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Konstantinos N. Fragoulis, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliations:
                  Alfa Institute of Biomedical Sciences, Athens, Greece, 
                  Department of Medicine, “Henry Dunant” Hospital, Athens, Greece
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ioannis Karydis
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Alfa Institute of Biomedical Sciences, Athens, Greece
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: December 20, 2006</li>
    <li>DOI: 10.1371/journal.pone.0000011</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000011-t001" data-doi="info:doi/10.1371/journal.pone.0000011" data-uri="info:doi/10.1371/journal.pone.0000011.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000011.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000011-t002" data-doi="info:doi/10.1371/journal.pone.0000011" data-uri="info:doi/10.1371/journal.pone.0000011.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000011.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000011">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000011" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Drug treatment is becoming more expensive due to the increased cost for the introduction of new drugs, and there seems to be an uneven distribution of medication cost for different therapeutic categories. We hypothesized that the cost of new antimicrobial agents may differ from that of other therapeutic categories and this may play a role in the stagnation of development of new antibiotics.</p>


<h3>Methodology/Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>We performed a pharmaco-economical comparative analysis of the drug cost of treatment for new agents introduced in the United States drug market in various therapeutic categories. We calculated the drug cost (in US dollars) of a ten-day treatment of all new drugs approved by the FDA during the period between January 1997 and July 2003, according to the 2004 Red Book Pharmacy's Fundamental Reference. New anti-neoplastic agents were found to be the most expensive drugs in comparison to all other therapeutic categories, with a median ten-day drug-treatment cost of US$848 compared to the median ten-day drug-treatment costs of all other categories ranging from US$29 to US$301. On the other hand, new antimicrobial drugs were found to be much less expensive, with a median ten-day drug-treatment cost of US$137 and $US85 for all anti-microbial agents and for anti-microbial agents excluding anti-HIV medications, respectively.</p>


<h3>Conclusions/Significance</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>The drug-treatment cost of new medications varies considerably by different therapeutic categories. This fact may influence industry decisions regarding the development of new drugs and may play a role in the shortage of new antimicrobial agents in the fight against the serious problem of antimicrobial resistance.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Falagas ME, Fragoulis KN, Karydis I (2006) A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories. PLoS ONE 1(1):
          e11.
            doi:10.1371/journal.pone.0000011</p><p><strong>Academic Editor: </strong>Bernhard Baune, James Cook University, Australia</p><p><strong>Received:</strong> August 28, 2006; <strong>Accepted:</strong> September 14, 2006; <strong>Published:</strong> December 20, 2006</p><p><strong>Copyright:</strong> © 2006 Falagas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>No funding was received.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>The investment of societies around the world on biomedical research leads to important developments including the continuous discovery of new pharmaceutical compounds. It is not clear, however, whether newly developed and approved drugs cover all therapeutic areas in a relatively uniform manner. Different reasons might be postulated with respect to the driving forces of drug development <a href="#pone.0000011-DiMasi1">[1]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Some may argue that more drugs are being developed in areas where the benefits to the society are maximized whereas others may claim that the direction is led to where the economic incentive for the pharmaceutical industry is higher <a href="#pone.0000011-DiMasi2">[2]</a>–<a href="#pone.0000011-DiMasi3">[5]</a>. A third reason may be a mounting social pressure from rising prevalence and incidence of certain health problems. Other reasons, which may influence drug development, may include the failure of current medications to solve existing health problems or the identification of new diseases such as the highlighted example of AIDS. The problem of new drugs–usually more expensive - substituting for older ones with similar chemical structure, which are loosing patent privileges, is thought to be one of the factors contributing to the increasing annual drug expenditure around the world.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>The problem of shortage of new anti-microbial agents has been well described in the medical literature <a href="#pone.0000011-Shah1">[6]</a>. This disturbing fact is occurring despite the gradually increasing prevalence of microbial resistance to existing antibiotics in various parts of the word <a href="#pone.0000011-Falagas1">[7]</a>–<a href="#pone.0000011-Falagas2">[9]</a>. A significant reduction (56%) of new approvals of antibacterial agents occurred during the period 1998–2002 compared to the period 1983–1987. In addition, the fact that only 6 out of 506 drugs disclosed in the development programs of the largest pharmaceutical and biotechnology companies are antibacterial agents is really distressing <a href="#pone.0000011-Spellberg1">[10]</a>.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>We hypothesized that the cost of new antimicrobial agents compared to new medications in other therapeutic areas may be a reason that plays a significant role in the relatively stagnated market of new anti-microbial agents, especially for non-HIV infectious diseases. Thus, we performed a pharmaco-economical study in order to analyze the cost of newly approved drugs and compare the overall treatment cost for new drugs between different therapeutic categories.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3><a id="article1.body1.sec2.p1" name="article1.body1.sec2.p1"></a><p>For the purpose of our study we analyzed data regarding original new drugs applications approved by the U.S. Food and Drug Administration (FDA) from January 1997 to July 2003. The data were obtained from the FDA website <a href="#pone.0000011-www.fda.gov1">[11]</a>. Based on the FDA definition of original new drugs, compounds that have the same chemical structure with an already approved medication are not considered new drugs.</p>
<a id="article1.body1.sec2.p2" name="article1.body1.sec2.p2"></a><p>In order to conduct our analysis, we classified each new drug in one of sixteen main therapeutic categories. However, four therapeutic categories were excluded from further analysis because of the small number of new drugs developed in each category. The excluded categories were: contrast agents [including 3 new drugs (Tc-99m depreotide, Tc-99m apcitide, and human albumin microspheres)], antidotes [including 1 new drug (fomepizole)], ear, nose and throat drugs [including 1 new drug (cevimeline)], and anesthesiology drugs (there was no new medication in this category during the study period). In addition, urea C-14 was not included in the gastrointestinal category since it is used exclusively for diagnostic purposes.</p>
<a id="article1.body1.sec2.p3" name="article1.body1.sec2.p3"></a><p>The cost of each new drug was determined using the Average Wholesale Price found in the Red Book Pharmacy's Fundamental Reference, 2004 edition <a href="#pone.0000011-Red1">[12]</a>. In order to compare the treatment cost of new drugs for different therapeutic categories, we made several assumptions. First, we calculated the cost of a ten-day drug-treatment for each new drug. For drugs that are used for a shorter period than ten days, we defined as “ten-day drug-treatment cost”, the price of the drug formulation with the fewer possible units of the medication required for each patient. We then calculated the median, mean, and the range of the ten-day drug-treatment cost of new drugs in the defined therapeutic categories.</p>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>One hundred and twenty-nine new drugs were approved by the FDA during the study period (January 1997 to July 2003). In <a href="#pone-0000011-t001">Table 1</a> we present 124 new drugs approved, classified in 12 therapeutic categories that we analyzed further. In <a href="#pone-0000011-t002">Table 2</a> we present the number of new drugs by therapeutic category as well as summary data on the drug cost of a ten-day treatment. All drug prices were presented in 2004 U.S. dollars (USD).</p>
<div class="figure" id="pone-0000011-t001"><div class="img"><a name="pone-0000011-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000011.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000011" data-uri="info:doi/10.1371/journal.pone.0000011.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000011.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000011.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000011.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000011.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000011.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000011.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000011.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000011.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000011.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Original new drugs in different therapeutic categories by chronological order of approval from the FDA (January 1997–July 2003).</span></strong></p><span>doi:10.1371/journal.pone.0000011.t001</span></div><div class="figure" id="pone-0000011-t002"><div class="img"><a name="pone-0000011-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000011.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000011" data-uri="info:doi/10.1371/journal.pone.0000011.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000011.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000011.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000011.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000011.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000011.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000011.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000011.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000011.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000011.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Number of original new drugs and ten-day treatment cost of different therapeutic categories (in USD - 2004).</span></strong></p><span>doi:10.1371/journal.pone.0000011.t002</span></div><a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>The categories with the most expensive new medications were the antineoplastic and immunosuppressive agents, the drugs for the respiratory tract, and the cardiovascular medications. The median, mean, and range of the drug cost of a ten-day treatment with new anti-neoplastic agents were 848, 1,455, and 41–4,182 USD respectively. The corresponding numbers for the drug cost of treatment with new agents involving the respiratory system were 301, 264 and 7–1300 USD, for cardiovascular new agents 184, 969 and 14–7,912 USD, and for new anti-infectious agents 137, 468 and 14–3,682 USD. The median, mean, and range of the drug cost of a ten-day treatment with new agents used for the management of the HIV infection were 178, 302, and 105–1,080 USD respectively; the corresponding numbers for non-HIV antimicrobial agents were 85, 600, and 14–3,682 USD.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>We studied the drug cost of the treatment of new agents to examine whether there are any important differences between the various therapeutic categories. It is interesting that the cost of treatment of new antineoplastic and immunosuppressive drugs is, by far, the highest compared to all other therapeutic categories. The drug-treatment cost of agents from the respiratory system and cardiovascular system category followed the anti-neoplastic agents category. The high drug cost, combined with the long duration of diseases for which most of these agents are prescribed, may explain the huge sales revenues from these drugs.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>The median drug cost of a ten-day treatment of an antineoplastic agent was actually more than 6 times higher than the respective value in the category of antimicrobial agents; the difference is even more pronounced if someone excludes from the category of new antimicrobials, the drugs for the management of HIV infection. In fact, anti-neoplastic agents are given in prolonged cycles of chemotherapy and it is, therefore, reasonable to assume that our analysis actually underestimated the true drug cost of treatment for anti-neoplastic agents.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>Although, we did not make an attempt to study the differences in the cost of pre-marketing development of new drugs in different therapeutic categories, we postulate that the observed differences in drug-treatment cost, and subsequently the drug sales revenue, may play a role in the decision making process for the introduction of new drugs. It may also be one of the factors that has led to a relative shortage of new antibiotics. It should be emphasized that the pre-marketing cost of development of new chemical entities has been found to be higher for anti-infective agents compared to several other categories of drugs, including cardiovascular and neuro-pharmacological agents <a href="#pone.0000011-DiMasi1">[1]</a>.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>Our study has several limitations. First, we had to measure the drug cost of a defined period of treatment (ten-day treatment) in order to provide some comparative estimates of treatment cost with new drugs in different therapeutic categories. The selection of any time period (e.g. one-day, one-week, one-month, etc) for our comparative analysis would have its own advantages and disadvantages given that the duration of treatment differs considerably for the numerous acute, sub-acute, and chronic diseases. Second, we calculated only the drug-treatment cost without taking into consideration other important factors that influence the cost of medical care, including cost related to the administration of parenteral medications. Third, we did not take into account data about the effectiveness and safety of new drugs in order to perform a comparative assessment of the cost-effectiveness of new agents in different therapeutic categories.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>In addition, we did not examine the reasons for the considerable differences in the drug-treatment cost of with newly approved agents. Several factors may contribute to the observed differences in the cost; including the cost of development, production, and introduction of new drugs into the clinical practice <a href="#pone.0000011-Emanuel1">[13]</a>. Specifically, the cost of the infrastructure necessary for the development of new drugs may differ for different therapeutic categories. Furthermore, the cost of clinical trials, required for the approval of new drugs, may be also be different for the various therapeutic categories <a href="#pone.0000011-Kelloff1">[14]</a>, <a href="#pone.0000011-Levy1">[15]</a>. For example, a longer follow up period of observation is necessary for the determination of the outcome in clinical trials studying anti-neoplastic compared to antibacterial agents. Moreover, differences in the failure rate of new drugs to successfully complete phases I to IV of clinical trials, may contribute to the increased cost of production of new anti-neoplastic and immunosuppressive drugs.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6"></a><p>In conclusion, we found considerable differences in the drug-treatment cost of new medications between the various therapeutic categories. It is interesting to note that new drugs used for the treatment of infections are less expensive, especially if one excludes new agents for the management of HIV infection. It should be appreciated that the number of new antimicrobial drugs is actually quite high despite relatively low ten-day cost. However, this high number is obviously not sufficient in light of the prevalence/incidence of infectious diseases and the antimicrobial resistance. Additional comparative pharmaco-economical studies are needed to address the question whether new drugs provide good value for their cost. There is also a need to further explore the differences in the cost of new agents and the role they play in the relative stagnation in the development of new antibiotics, in an era when they are urgently needed because of the pandemic of antimicrobial resistance.</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>MEF had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: MF. Analyzed the data: MF KF IK. Wrote the paper: MF IK. Other: Collected data. KF</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000011-DiMasi1" id="pone.0000011-DiMasi1"></a>DiMasi JA, Caglarcan E, Wood-Armany M (2001) Emerging role of pharmacoeconomics in the research and development decision-making process. Pharmacoeconomics  19: 753–766.  <ul class="find" data-citedArticleID="913670" data-doi="10.2165/00019053-200119070-00004"><li><a href="http://dx.doi.org/10.2165/00019053-200119070-00004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Emerging+role+of+pharmacoeconomics+in+the+research+and+development+decision-making+process." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Emerging+role+of+pharmacoeconomics+in+the+research+and+development+decision-making+process.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000011-DiMasi2" id="pone.0000011-DiMasi2"></a>DiMasi JA, Hansen RW, Grabowski HG, Lasagna L (1995) Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry. Pharmacoeconomics  7: 152–169.  <ul class="find" data-citedArticleID="913672" data-doi="10.2165/00019053-199507020-00007"><li><a href="http://dx.doi.org/10.2165/00019053-199507020-00007" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Research+and+development+costs+for+new+drugs+by+therapeutic+category.+A+study+of+the+US+pharmaceutical+industry." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Research+and+development+costs+for+new+drugs+by+therapeutic+category.+A+study+of+the+US+pharmaceutical+industry.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000011-Mehl1" id="pone.0000011-Mehl1"></a>Mehl B, Santell J (2001) Projecting future drug expenditures. Am J Health Syst Pharm  58: 125–33.  <ul class="find" data-citedArticleID="913688"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Projecting+future+drug+expenditures.&amp;auth=&amp;atitle=Projecting+future+drug+expenditures." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Projecting+future+drug+expenditures." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Projecting+future+drug+expenditures.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000011-Letizia1" id="pone.0000011-Letizia1"></a>Letizia C (1995) Pharmacoeconomics: an emerging discipline. Qual Assur  4: 68–74.  <ul class="find" data-citedArticleID="913684"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Pharmacoeconomics%3A+an+emerging+discipline.&amp;auth=&amp;atitle=Pharmacoeconomics%3A+an+emerging+discipline." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pharmacoeconomics%3A+an+emerging+discipline." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pharmacoeconomics%3A+an+emerging+discipline.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000011-DiMasi3" id="pone.0000011-DiMasi3"></a>DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ  22: 151–85.  <ul class="find" data-citedArticleID="913674" data-doi="10.1016/s0167-6296(02)00126-1"><li><a href="http://dx.doi.org/10.1016/s0167-6296(02)00126-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+price+of+innovation%3A+new+estimates+of+drug+development+costs." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+price+of+innovation%3A+new+estimates+of+drug+development+costs.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000011-Shah1" id="pone.0000011-Shah1"></a>Shah PM (2005) The need for new therapeutic agents: what is the pipeline? Clin Microbiol Infect  11: (Suppl 3)36–42.  <ul class="find" data-citedArticleID="913692" data-doi="10.1111/j.1469-0691.2005.01141.x"><li><a href="http://dx.doi.org/10.1111/j.1469-0691.2005.01141.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+need+for+new+therapeutic+agents%3A+what+is+the+pipeline%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+need+for+new+therapeutic+agents%3A+what+is+the+pipeline%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000011-Falagas1" id="pone.0000011-Falagas1"></a>Falagas ME, Kasiakou SK, Nikita D, Morfou P, Georgoulias G, et al.  (2006) Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital. BMC Infect Dis  6: 99.  <ul class="find" data-citedArticleID="913678" data-doi="10.1186/1471-2334-6-99"><li><a href="http://dx.doi.org/10.1186/1471-2334-6-99" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Secular+trends+of+antimicrobial+resistance+of+blood+isolates+in+a+newly+founded+Greek+hospital." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Secular+trends+of+antimicrobial+resistance+of+blood+isolates+in+a+newly+founded+Greek+hospital.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000011-Tablot1" id="pone.0000011-Tablot1"></a>Tablot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, et al.  (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Disease Society of America. Clin Infect Dis  42: 657–68.  <ul class="find" data-citedArticleID="913696" data-doi="10.1086/499819"><li><a href="http://dx.doi.org/10.1086/499819" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Bad+bugs+need+drugs%3A+an+update+on+the+development+pipeline+from+the+Antimicrobial+Availability+Task+Force+of+the+Infectious+Disease+Society+of+America." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Bad+bugs+need+drugs%3A+an+update+on+the+development+pipeline+from+the+Antimicrobial+Availability+Task+Force+of+the+Infectious+Disease+Society+of+America.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000011-Falagas2" id="pone.0000011-Falagas2"></a>Falagas ME, Karveli EA (2006) World Wide Web resources on antimicrobial resistance. Clin Infect Dis  43: 630–3.  <ul class="find" data-citedArticleID="913680" data-doi="10.1086/506443"><li><a href="http://dx.doi.org/10.1086/506443" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=World+Wide+Web+resources+on+antimicrobial+resistance." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22World+Wide+Web+resources+on+antimicrobial+resistance.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000011-Spellberg1" id="pone.0000011-Spellberg1"></a>Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis  38: 1279–86.  <ul class="find" data-citedArticleID="913694" data-doi="10.1086/420937"><li><a href="http://dx.doi.org/10.1086/420937" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Trends+in+antimicrobial+drug+development%3A+implications+for+the+future." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Trends+in+antimicrobial+drug+development%3A+implications+for+the+future.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000011-www.fda.gov1" id="pone.0000011-www.fda.gov1"></a>  
                  <a href="http://www.fda.gov">www.fda.gov</a> (accessed on 05/20/2005).  <ul class="find-nolinks"></ul></li><li><span class="label">12.
              </span><a name="pone.0000011-Red1" id="pone.0000011-Red1"></a>Red Book Pharmacy's Fundamental Reference (2004) Thomson, Montvale: New Jersey.   <ul class="find-nolinks"></ul></li><li><span class="label">13.
              </span><a name="pone.0000011-Emanuel1" id="pone.0000011-Emanuel1"></a>Emanuel EJ, Scnipper LE, Kamin DY, Levinson J, Lichter AS (2003) The costs of conducting clinical research. J Clin Oncol  21: 4145–4150.  <ul class="find" data-citedArticleID="913676"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+costs+of+conducting+clinical+research.&amp;auth=&amp;atitle=The+costs+of+conducting+clinical+research." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+costs+of+conducting+clinical+research." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+costs+of+conducting+clinical+research.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000011-Kelloff1" id="pone.0000011-Kelloff1"></a>Kelloff GJ, Sigma CC (2005) New science-based endpoints to accelerate oncology drug development. Eur J Cancer  41: 491–501.  <ul class="find" data-citedArticleID="913682" data-doi="10.1016/j.ejca.2004.12.006"><li><a href="http://dx.doi.org/10.1016/j.ejca.2004.12.006" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=New+science-based+endpoints+to+accelerate+oncology+drug+development." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22New+science-based+endpoints+to+accelerate+oncology+drug+development.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000011-Levy1" id="pone.0000011-Levy1"></a>Levy C, Bonastre J (2003) The cost of chemotherapy. Bull Cancer  90: 976–982.  <ul class="find" data-citedArticleID="913686"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+cost+of+chemotherapy.&amp;auth=&amp;atitle=The+cost+of+chemotherapy." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+cost+of+chemotherapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+cost+of+chemotherapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.XML" value="48394"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.PDF" value="54848"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t001.PNG_L" value="245138"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t001.PNG_M" value="38078"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t001.PNG_S" value="2438"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t001.TIF" value="7961610"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t001.PNG_I" value="15534"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t002.PNG_L" value="104635"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t002.PNG_M" value="14154"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t002.PNG_S" value="1867"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t002.TIF" value="7068870"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000011.t002.PNG_I" value="6056"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000011&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000011" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000011&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000011&volume=&issue=&title=A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories&author_name=Matthew%20E.%20Falagas%2C%20Konstantinos%20N.%20Fragoulis%2C%20Ioannis%20Karydis&start_page=1&end_page=4" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000011" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011&amp;t=A%20Comparative%20Study%20on%20the%20Cost%20of%20New%20Antibiotics%20and%20Drugs%20of%20Other%20Therapeutic%20Categories" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011&title=A%20Comparative%20Study%20on%20the%20Cost%20of%20New%20Antibiotics%20and%20Drugs%20of%20Other%20Therapeutic%20Categories&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011&amp;title=A%20Comparative%20Study%20on%20the%20Cost%20of%20New%20Antibiotics%20and%20Drugs%20of%20Other%20Therapeutic%20Categories" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000011&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000011';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20A%20Comparative%20Study%20on%20the%20Cost%20of%20New%20Antibiotics%20and%20Drugs%20of%20Other%20Therapeutic%20Categories http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000011" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000011" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">










          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antibiotics%22" title="Search for articles in the subject area:'Antibiotics'"><div class="flagText">Antibiotics</div></a>
              <div data-categoryid="42767" data-articleid="22862"
                   data-categoryname="Antibiotics"
                   class="flagImage" title="Flag 'Antibiotics' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antimicrobials%22" title="Search for articles in the subject area:'Antimicrobials'"><div class="flagText">Antimicrobials</div></a>
              <div data-categoryid="42703" data-articleid="22862"
                   data-categoryname="Antimicrobials"
                   class="flagImage" title="Flag 'Antimicrobials' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drug+research+and+development%22" title="Search for articles in the subject area:'Drug research and development'"><div class="flagText">Drug research and development</div></a>
              <div data-categoryid="18001" data-articleid="22862"
                   data-categoryname="Drug research and development"
                   class="flagImage" title="Flag 'Drug research and development' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drug+therapy%22" title="Search for articles in the subject area:'Drug therapy'"><div class="flagText">Drug therapy</div></a>
              <div data-categoryid="18461" data-articleid="22862"
                   data-categoryname="Drug therapy"
                   class="flagImage" title="Flag 'Drug therapy' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Drugs%22" title="Search for articles in the subject area:'Drugs'"><div class="flagText">Drugs</div></a>
              <div data-categoryid="18617" data-articleid="22862"
                   data-categoryname="Drugs"
                   class="flagImage" title="Flag 'Drugs' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Endocrinology%22" title="Search for articles in the subject area:'Endocrinology'"><div class="flagText">Endocrinology</div></a>
              <div data-categoryid="7525" data-articleid="22862"
                   data-categoryname="Endocrinology"
                   class="flagImage" title="Flag 'Endocrinology' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Immunosuppressives%22" title="Search for articles in the subject area:'Immunosuppressives'"><div class="flagText">Immunosuppressives</div></a>
              <div data-categoryid="26253" data-articleid="22862"
                   data-categoryname="Immunosuppressives"
                   class="flagImage" title="Flag 'Immunosuppressives' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Infectious+diseases%22" title="Search for articles in the subject area:'Infectious diseases'"><div class="flagText">Infectious diseases</div></a>
              <div data-categoryid="2603" data-articleid="22862"
                   data-categoryname="Infectious diseases"
                   class="flagImage" title="Flag 'Infectious diseases' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=2702'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=6949'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=7283&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
